Enoch Kariuki
CIK: 0001843119
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ZNTL
Zentalis Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
About Kariuki Enoch
Kariuki Enoch (SEC CIK 0001843119) files insider reports with the SEC as Director of Zentalis Pharmaceuticals, Inc. (ZNTL).
Signal8 holds 2 ownership filings by Kariuki Enoch, all Form 4s, filed between Jun 18, 2025 and Jun 18, 2026. Those filings report 2 transactions, from Jun 17, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kariuki Enoch's filings is in SAN DIEGO, CA.
Recent filings by Kariuki Enoch
Other insiders filing for Zentalis Pharmaceuticals, Inc. (ZNTL)
- Bruns Ingmar, Chief Medical Officer
- WALTERS GROUP, 10% Owner
- Johnson David Michael, Director
- Skvarka Jan, Director
- Walker Luke Nathaniel, Director
- Myers Scott Dunseth, Director